Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Actavis

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug

order to pay down a very high level of debt stemming from its $39bn acquisition of Allergan’s generics business Actavis in 2015.

Axovant poaches Allergan’s and Teva’s chief medical and science officers

Axovant poaches Allergan’s and Teva’s chief medical and science officers Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more

Morning brief: Roche raises outlook for 2018, ASCO abstracts revealed and more The $64bn sum makes the deal the biggest pharma M&A transaction since Actavis bought Allergan in 2015 for $70.5bn.

Shire warms to Takeda’s latest offer, extending deadline

Shire warms to Takeda’s latest offer, extending deadline Analysts suggest however that negative sentiment could still scupper a deal that is by far the largest ever undertaken by the company - and the biggest in pharma since the $70bn

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out Allergan - also headquartered in Ireland - is no stranger to the M&A game having been bulked up by serial acquisitions in recent years, including a $66bn merger with Actavis in 2014

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell - Cake

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics